ORTHOCELL
LIVE

Serial Number

79246526

Owner

Orthocell Limited

Attorney

Matthew J. Stark

Filing Date

Oct 24, 2018

Add to watchlist:

No watchlists yet
View on USPTO

ORTHOCELL Trademark

Serial Number: 79246526 • Registration: 6004489

ORTHOCELL is a trademark filed by Orthocell Limited on October 24, 2018. The trademark is classified under Class 5 (Pharmaceuticals), Class 42 (Computer & Scientific), Class 44 (Medical Services). The application is currently registered and active.

Owner Contact Info

Orthocell Limited (15 trademarks)

Building 191,

Entity Type: 99

Trademark Details

Filing Date

October 24, 2018

Registration Date

March 10, 2020

Published for Opposition

December 24, 2019

Goods & Services

Stem cells for medical purposes; collagen for medical use; biodegradable implants comprising biological material being living cells and implantable scaffolds comprising biological materials for use in guided tissue regeneration; implant materials comprising biological material being living cells and implantable scaffolds comprising biological materials for use in guided tissue regeneration in surgery; implantable materials comprising biological material being living cells and implantable scaffolds comprising biological materials for use in guided tissue regeneration; implants comprising biological material being living cells and implantable scaffolds comprising biological materials for guided tissue regeneration; surgical implants comprised of living cells; therapeutic agents, namely, therapeutic agents for tissue regeneration; therapeutic biological products, namely, biological cell cultures for medical purposes, Biological tissue grafts, Biological preparations for guided tissue regeneration; medical preparations for the treatment of tissue repair; guided tissue regeneration materials, namely, implants comprising biological materials being living cells and implantable scaffolds comprising biological materials; biological preparations for medical purposes for use in guided tissue regeneration for tissue repair; tissue-regenerative medical preparations for use in guided tissue regeneration of damaged tissue; biological materials for medical use, namely, surgical implants comprised of living cells, Biological tissue grafts, Biological materials for medical purposes being living cells and implantable scaffolds comprising biological materials; Collagen for medical purposes, namely, collagen based scaffolding for biomechanical support and stabilisation; Cells for medical or clinical use, namely, cellular therapeutic tendon and cartilage regeneration products

Advisory services relating to medical services; medical services; medical advisory services; medical care services; medical health assessment services; medical treatment services of regeneration of damaged tissue and for tissue repair; provision of medical information; provision of medical services; medical services, including those relating to biomechanical and cellular therapeutic medical techniques

Medical research; scientific and technological services, namely, product research and development relating to tissue regeneration products and techniques in the field of biomechanical and cellular therapeutic medical techniques; scientific research relating to biology; scientific and technological research and design services relating to biomechanical and cellular therapeutic medical techniques

Filing History

COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED
Mar 10, 2025 REM3
FINAL DECISION TRANSACTION PROCESSED BY IB
Aug 7, 2020 FINO
FINAL DISPOSITION NOTICE SENT TO IB
Jul 19, 2020 FICS
FINAL DISPOSITION PROCESSED
Jul 19, 2020 FIMP
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Jun 10, 2020 FICR
REGISTERED-PRINCIPAL REGISTER
Mar 10, 2020 R.PR
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Dec 24, 2019 NPUB
PUBLISHED FOR OPPOSITION
Dec 24, 2019 PUBO
NOTIFICATION PROCESSED BY IB
Dec 20, 2019 GPNX
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Dec 4, 2019 OPNS
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
Dec 4, 2019 OP2R
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Dec 4, 2019 NONP
ASSIGNED TO LIE
Nov 15, 2019 ALIE
APPROVED FOR PUB - PRINCIPAL REGISTER
Nov 12, 2019 CNSA
EXAMINER'S AMENDMENT ENTERED
Oct 29, 2019 XAEC
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Oct 29, 2019 GNEN
EXAMINERS AMENDMENT E-MAILED
Oct 29, 2019 GNEA
EXAMINERS AMENDMENT -WRITTEN
Oct 29, 2019 CNEA
NOTIFICATION OF FINAL REFUSAL EMAILED
Sep 23, 2019 GNFN
FINAL REFUSAL E-MAILED
Sep 23, 2019 GNFR
FINAL REFUSAL WRITTEN
Sep 23, 2019 CNFR
TEAS/EMAIL CORRESPONDENCE ENTERED
Aug 9, 2019 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Aug 9, 2019 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Aug 9, 2019 TROA
REFUSAL PROCESSED BY IB
Mar 2, 2019 RFNT
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Feb 12, 2019 RFCS
REFUSAL PROCESSED BY MPU
Feb 12, 2019 RFRR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Feb 6, 2019 RFCR
NON-FINAL ACTION WRITTEN
Feb 5, 2019 CNRT
ASSIGNED TO EXAMINER
Jan 31, 2019 DOCK
APPLICATION FILING RECEIPT MAILED
Dec 4, 2018 MAFR
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Nov 30, 2018 NWOS
SN ASSIGNED FOR SECT 66A APPL FROM IB
Nov 29, 2018 REPR